Unacceptable death rates end animal cloning trials
Cloning presents significant health risks
A leading animal cloning organisation, New Zealand’s AgResearch, has ended cloning trials because of unacceptable death rates. But the science agency says it will continue to design genetically engineered animals using new research methods. AgResearch says that arthritis, lameness, blood poisoning and pneumonia were among the causes of goat, sheep and cattle deaths. Only about 10% of cloned animals survived the trials. A number of calves from mid gestation onwards either spontaneously aborted or died. ~ Stuff.co.nz, Feb 21
Unacceptable death rates end animal cloning trials
Jared Yee
cloning
Latest posts by Mumbai (see all)
- Prescribe morning-after pills to young teenagers, say US pediatric group - November 30, 2012
- Bahrain sentences protest docs to prison - November 28, 2012
- Terry Pratchett assisted suicide documentary wins International Emmy - November 27, 2012
More Stories
Commercial surrogacy hammered in Rome
Momentum in growing in Europe for a global ban on surrogacy. Italy’s Prime Minister, Giorgia Meloni has blasted surrogacy as...
Canadian man wins right to a government-funded ‘penile-preserving vaginoplasty’
An Ontario man has won the right to government-funded gender-affirming surgery in the United States which will give him both...
14-year-olds will be able to change their gender legally in Germany
German lawmakers have made it easier for transgender, intersex and non-binary people to change their official gender. A controversial Self-Determination...
Gaza’s IVF embryos have been destroyed by Israeli bombs
One of the many casualties of the war in Gaza has been the embryos and gametes stored at the Al-Basma IVF...
UK doctors fear toxic abuse over their research on trans issues
Fallout from the Cass review of transgender medical treatment in the UK continues. The Guardian interviewed doctors and researchers who...
Utah’s new stem cell law undermines FDA’s authority
The state of Utah has just enacted a law permitting patients to receive medical treatments using placental stem cells without formal approval...
